BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32504783)

  • 1. Ganoderma lucidum: A rational pharmacological approach to surmount cancer.
    Ahmad MF
    J Ethnopharmacol; 2020 Oct; 260():113047. PubMed ID: 32504783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of
    González A; Atienza V; Montoro A; Soriano JM
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganoderma lucidum (Reishi mushroom) for cancer treatment.
    Jin X; Ruiz Beguerie J; Sze DM; Chan GC
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007731. PubMed ID: 22696372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganoderma lucidum (Reishi) in cancer treatment.
    Sliva D
    Integr Cancer Ther; 2003 Dec; 2(4):358-64. PubMed ID: 14713328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review).
    Cizmarikova M
    Int J Med Mushrooms; 2017; 19(10):861-877. PubMed ID: 29256841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganoderma lucidum Polysaccharides as An Anti-cancer Agent.
    Sohretoglu D; Huang S
    Anticancer Agents Med Chem; 2018; 18(5):667-674. PubMed ID: 29141563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganoderma lucidum: A potential source to surmount viral infections through β-glucans immunomodulatory and triterpenoids antiviral properties.
    Ahmad MF; Ahmad FA; Khan MI; Alsayegh AA; Wahab S; Alam MI; Ahmed F
    Int J Biol Macromol; 2021 Sep; 187():769-779. PubMed ID: 34197853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
    Hsieh TC; Wu JM
    Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganoderma lucidum and its pharmaceutically active compounds.
    Boh B; Berovic M; Zhang J; Zhi-Bin L
    Biotechnol Annu Rev; 2007; 13():265-301. PubMed ID: 17875480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic triterpenoids from Ganoderma lucidum.
    Cheng CR; Yue QX; Wu ZY; Song XY; Tao SJ; Wu XH; Xu PP; Liu X; Guan SH; Guo DA
    Phytochemistry; 2010 Sep; 71(13):1579-85. PubMed ID: 20615519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
    Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
    Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damaging potential of Ganoderma lucidum extracts.
    Gurovic MSV; Viceconte FR; Pereyra MT; Bidegain MA; Cubitto MA
    J Ethnopharmacol; 2018 May; 217():83-88. PubMed ID: 29421594
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ahmad MF; Ahmad FA; Zeyaullah M; Alsayegh AA; Mahmood SE; AlShahrani AM; Khan MS; Shama E; Hamouda A; Elbendary EY; Attia KAHA
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111092
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
    Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
    Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement.
    Ahmad MF
    Biomed Pharmacother; 2018 Nov; 107():507-519. PubMed ID: 30114634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.
    Sliva D; Labarrere C; Slivova V; Sedlak M; Lloyd FP; Ho NW
    Biochem Biophys Res Commun; 2002 Nov; 298(4):603-12. PubMed ID: 12408995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of Ganoderma lucidum basidiocarps cultivated on alternative and commercial substrate.
    Cilerdžić J; Vukojević J; Stajić M; Stanojković T; Glamočlija J
    J Ethnopharmacol; 2014 Aug; 155(1):312-9. PubMed ID: 24879959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
    Liang C; Tian D; Liu Y; Li H; Zhu J; Li M; Xin M; Xia J
    Eur J Med Chem; 2019 Jul; 174():130-141. PubMed ID: 31035236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
    Xu Z; Chen X; Zhong Z; Chen L; Wang Y
    Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure Identification and Anti-Cancer Pharmacological Prediction of Triterpenes from Ganoderma lucidum.
    Shao Y; Qiao L; Wu L; Sun X; Zhu D; Yang G; Zhang X; Mao X; Chen W; Liang W; Zhang Y; Zhang L
    Molecules; 2016 May; 21(5):. PubMed ID: 27213329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.